药靶抗体
            选项
        
        
    - 
                        Ramucirumab (anti-VEGFR2)关联靶标: KDR- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level < 0.01EU/μg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
 CAS号 : 947687-13-0 Compound CID : 168010175IUPAC Name: silverSMILES: [Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag]InChIKey: JPWNEBNBYYVUBY-UHFFFAOYSA-NInChI: InChI=1S/13Ag
- 
                        Olinvacimab (anti-VEGFR2)关联靶标: KDR- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 大鼠(Rat), 小鼠(Mouse)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
 CAS号 : 2095504-49-5SMILES: [Olinvacimab]
- 
                        Vulinacimab (anti-VEGFR2)关联靶标: KDR- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level < 0.01EU/μg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
 CAS号 : 2250342-36-8
- 
                        ITRI patent anti-CD34 (anti-CD34)关联靶标: CD34- 简短描述: Purity≥95% (SDS-PAGE&SEC-HPLC); Endotoxin Level< 0.01EU/μg; Human IgG1; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 小鼠(Mouse)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
 
 首页
首页 400-620-6333
400-620-6333



